Background Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder caused by the loss of motor neurons. Its etiology remains unknown, but several hypothesis have been raised to explain motor neuron death, including oxidative stress. Dysregulation of cellular iron metabolism can lead to increased oxidative stress, and existing data argue for a role of iron metabolism in ALS pathophysiology. Methods We performed a retrospective analysis of iron metabolism (IM) variables (serum levels of iron, transferrin, ferritin, and TSC for Transferrin Saturation Coefficient) in a cohort of 694 ALS patients and 297 healthy controls. Results Serum ferritin levels and TSC were higher, whereas serum transferrin levels were lower in ALS patients than controls. In addition, patients with a high level serum ferritin had a shorter survival time compared to those with low level serum ferritin (618 days versus 921 days for men subgroup; p = .007). Site of onset and ALS-FRS score were not associated with IM variables. Conclusion This study suggests that ALS patients may have increased iron storage, as measured by increased serum ferritin and TSC. Elevated serum ferritin may also have a deleterious impact on survival in ALS.
Barber SC, Mead RJ, Shaw PJ (2006) Oxidative stress in ALS: a mechanism of neurodegeneration and a therapeutic target. Biochim Biophys Acta 1762: 1051–1067.
[3]
Nappi AJ, Vass E (2000) Iron, metalloenzymes and cytotoxic reactions. Cell Mol Biol (Noisy-le-grand) 46: 637–647.
[4]
Ince PG, Shaw PJ, Candy JM, Mantle D, Tandon L, et al. (1994) Iron, selenium and glutathione peroxidase activity are elevated in sporadic motor neuron disease. Neurosci Lett 182: 87–90.
[5]
Mizuno Y, Amari M, Takatama M, Aizawa H, Mihara B, et al. (2006) Transferrin localizes in Bunina bodies in amyotrophic lateral sclerosis. Acta Neuropathol 112: 597–603.
[6]
Goodall EF, Greenway MJ, van Marion I, Carroll CB, Hardiman O, et al. (2005) Association of the H63D polymorphism in the hemochromatosis gene with sporadic ALS. Neurology 65: 934–937.
[7]
Restagno G, Lombardo F, Ghiglione P, Calvo A, Cocco E, et al. (2007) HFE H63D polymorphism is increased in patients with amyotrophic lateral sclerosis of Italian origin. J Neurol Neurosurg Psychiatry 78: 327.
[8]
Sutedja NA, Sinke RJ, Van Vught PW, Van der Linden MW, Wokke JH, et al. (2007) The association between H63D mutations in HFE and amyotrophic lateral sclerosis in a Dutch population. Arch Neurol 64: 63–67.
[9]
Wang XS, Lee S, Simmons Z, Boyer P, Scott K, et al. (2004) Increased incidence of the Hfe mutation in amyotrophic lateral sclerosis and related cellular consequences. J Neurol Sci 227: 27–33.
Mitchell RM, Simmons Z, Beard JL, Stephens HE, Connor JR Plasma biomarkers associated with ALS, their relationship to iron homeostasis (2010) Muscle Nerve. 42: 95–103.
[12]
Qureshi M, Brown RH Jr, Rogers JT, Cudkowicz ME (2008) Serum ferritin and metal levels as risk factors for amyotrophic lateral sclerosis. Open Neurol J 2: 51–54.
[13]
Jeong SY, Rathore KI, Schulz K, Ponka P, Arosio P, et al. (2009) Dysregulation of iron homeostasis in the CNS contributes to disease progression in a mouse model of amyotrophic lateral sclerosis. J Neurosci 29: 610–619.
[14]
Brooks BR, Miller RG, Swash M, Munsat TL (2000) El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1: 293–299.
[15]
Arosio P, Levi S (2002) Ferritin, iron homeostasis, and oxidative damage. Free Radic Biol Med 33: 457–463.
[16]
De Domenico I, McVey Ward D, Kaplan J (2008) Regulation of iron acquisition and storage: consequences for iron-linked disorders. Nat Rev Mol Cell Biol 9: 72–81.
[17]
Kuhle J, Lindberg RL, Regeniter A, Mehling M, Steck AJ, et al.. (2009) Increased levels of inflammatory chemokines in amyotrophic lateral sclerosis. Eur J Neurol.
[18]
Gandon Y, Olivie D, Guyader D, Aube C, Oberti F, et al. (2004) Non-invasive assessment of hepatic iron stores by MRI. Lancet 363: 357–362.
[19]
Gonzalez de Aguilar JL, Echaniz-Laguna A, Fergani A, Rene F, Meininger V, et al. (2007) Amyotrophic lateral sclerosis: all roads lead to Rome. J Neurochem 101: 1153–1160.
[20]
Dupuis L, Pradat PF, Ludolph AC, Loeffler JP (2011) Energy metabolism in amyotrophic lateral sclerosis. Lancet Neurol 10: 75–82.
